Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Silence Therapeutics Plc LSE:SLN London Ordinary Share GB00B9GTXM62 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 70.00p 69.00p 70.00p - - - 12,500 08:18:29
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -20.5 -26.2 - 51.00

Silence Therapeutics Share Discussion Threads

Showing 50251 to 50274 of 50600 messages
Chat Pages: Latest  2012  2011  2010  2009  2008  2007  2006  2005  2004  2003  2002  2001  Older
DateSubjectAuthorDiscuss
04/10/2017
06:54
Arrowhead at 10 month highs
rogen83
04/10/2017
04:48
Sold 50% and stuck it into MTFB (Beaufort Securities price target of 100p) though I do reckon there's still 300p in Silence, in time
gersemi
04/10/2017
04:41
This will make some long term posters smile (if they are still around). It must be at least 13 or 14 years since my first SR Pharma investment and I have a significant loss over that time. But I am at last ready to rekindle my interest and look to get something back as my poor sixth sense, finally says the end game is not to far away. It's a relatively lower investment than the heady days, but I have instructed my broker to cash in everything else and go all in on SLN. So Bare, Doc,Frog, Buzzzz,Graham Browns Dad,Billy,Tonester,Digger,Geoffmanana,Sawbones,JBD, Rick and lots of others from the past (apologies for my poor memory)let's hope this is ends up being one for the old crowd! GLA
ukeagle2aus
29/9/2017
06:52
How long till we get an approach? Tick tock
rogen83
28/9/2017
21:15
Another very nice day for ARWR shareholders (up another 7% to $4.22). I bottled it on analyst day, so no longer have a direct interest, but might it be enough to push SLN through 200p tomorrow?
1gw
28/9/2017
16:40
So close...
1gw
28/9/2017
15:45
1gw today is the day!
djnzloop
28/9/2017
11:04
Could this be the day the share price gets back through 200p?
1gw
28/9/2017
08:23
Arrowhead stake now worth £20m or 30p of SLNs share price Good work Ali
rogen83
27/9/2017
10:22
Looking at the various holdings notices, I wonder if RG, RK, Spreadex and ING positions are linked. RG & RK notified 4.63% spreadbet position as of 20th September. Spreadex has notified 5.49% spreadbet position also as of 20th September. ING notified 5.35% shares position as of 20th September. So is it likely that the spreadex position is mainly the other side of the RG & RK positions, while the ING position is mainly the underlying asset to cover spreadex? If that's correct then (most of) the ING and spreadex positions have to be ignored when calculating the number of voting rights controlled by top shareholders, otherwise there's double-counting. Given the 0.72% increase in the ING position as of 25th September, perhaps RG and/or RK have increased their spreadbet positions a bit as of that date.
1gw
26/9/2017
07:46
Arrowhead up 20% all good for sln investment
doc robinson
22/9/2017
20:52
Good call on Woodford, djnzloop. So with Woodford below the notifiable threshold, I think the major shareholders, with total positions including derivatives, are now: 29.2% Richard Griffiths 20.6% Robert Keith 11.9% Invesco (from Annual Report) 7.7% Henderson (from Annual Report) 5.3% ING 5.3% Aviva That's 80% held between the top 6 investors, with another 2.8% held by Ali (according to annual report). Is it credible that ING is holding that position for its own account, or is it likely to be on behalf of a client or as the underlying asset for a derivative offered to a client?
1gw
22/9/2017
18:59
The more held in just a few hands the better. Liquidity is going to be at a premium so any whiff of a deal and this is going to squeeze like buggary
rogen83
22/9/2017
16:02
Griffiths & Keith now own near 50% - the picture is complete and once more, an absolute work of art to watch.
richie666
22/9/2017
15:27
Robert Keith up as well.
1gw
22/9/2017
14:21
So Aviva sold down on Wednesday but ING and more interestingly Richard Griffiths increased their holdings. Reassuring to see RG increasing as he has held for long time, and especially reassuring that the increase is all to "Richard Griffiths & Family" rather than one of his subsidiary companies. If he still sees value adding at these levels, that is good enough for me.
callumross
22/9/2017
09:42
callumross - I don't think the £8.56m is materially inaccurate, just a bit confusing. They are quoting the book value at 30th June, where "available for sale financial assets" were in the accounts at £8.555m. However, I do think the "up over 200%" is inaccurate. Silence purchased the stake at an average price of $1.65, so at a current price of about $3.50, the increase is $1.85, which is an increase of 112%, so the stake in $ terms is up over 100% since purchase, not over 200%. "That capitalises the business still at just £133 million with the valuation being backed by net cash of £29.8 million as at 30th June along with shares in US listed peer Arrowhead Pharmaceuticals (ARWR) valued at £8.56 million and which are up over 200% since Silence’s purchase."
1gw
22/9/2017
09:26
There is a material inaccuracy in that Align Research report Richie. They state the value of the Arrowhead stake as £8.56m. In fact at last nights close of $3.50 it is worth $24m or around £18m.
callumross
22/9/2017
07:54
Interesting that Align Research have put a link to their Silence update out this morning in an official RNS, entitled "Align Research updates"
1gw
22/9/2017
07:19
Note sounds very positive and is confident silence will be bought out very soon at a substantial premium.
doc robinson
22/9/2017
07:07
http://www.alignresearch.co.uk/silence-therapeutics/positive-rnai-results-silences-critics/
richie666
21/9/2017
10:43
Well this is all very nice. I thought the muted shareprice reaction to the alny news yesterday was rather strange - and but for what presumably was a very large seller feeding the buying interest I imagine we would have had a much stronger move yesterday. It will be good to see any holdings notices that come out of yesterday's volume.
1gw
21/9/2017
06:51
The recent director buys around 150p clearly aren't intended to make a 10%-20% gain. Likewise the last financing round at >200p. Everyone knows what the end game is here and I am expecting a nice steady rise up to 250-300p region ahead of the November capital markets day. Should be fun
rogen83
20/9/2017
19:46
ALNY or ARWR in would be interesting
djnzloop
Chat Pages: Latest  2012  2011  2010  2009  2008  2007  2006  2005  2004  2003  2002  2001  Older
Your Recent History
LSE
SLN
Silence Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190626 07:52:54